Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Expert Review of Anticancer Therapy
|
October 18, 2011
Raltitrexed in mesothelioma
Veerle F Surmont, Jan P van Meerbeeck
Critical Reviews in Oncology/Hematology
|
May 15, 2010
Malignant pleural mesothelioma: the standard of care and challenges for future management
Jan P van Meerbeeck, Arnaud Scherpereel, Veerle F Surmont, et al.
Expert Review of Anticancer Therapy
|
April 21, 2011
Malignant pleural mesothelioma: when is radiation therapy indicated?
Eric R E van Thiel, Veerle F Surmont, Jan P van Meerbeeck
Frontiers in Oncology
|
June 6, 2012
Investigational approaches for mesothelioma
Veerle F Surmont, Eric R E van Thiel, Karim Vermaelen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 31, 2015
Sunitinib (SU11248) in patients with chemo naive extensive small cell lung cancer or who have a 'chemosensitive' relapse: A single-arm phase II study (EORTC-08061)
Fatma Abdelraouf, Egbert Smit, Baktiar Hasan, et al.
Lung Cancer (Amsterdam, Netherlands)
|
April 17, 2002
Unexpected response of a pulmonary blastoma on radiotherapy: a case report and review of the literature
Veerle F Surmont, Rob J van Klaveren, Peter J C M Nowak, et al.
Cancers
|
July 9, 2022
External Validation of a Breath-Based Prediction Model for Malignant Pleural Mesothelioma
Eline Janssens, Eline Schillebeeckx, Kathleen Zwijsen, et al.
Journal of Breath Research
|
September 8, 2023
Determining the clinical utility of a breath test for screening an asbestos-exposed population for pleural mesothelioma: baseline results
Kathleen Zwijsen, Eline Schillebeeckx, Eline Janssens, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 2, 2011
A double-blind, randomised, placebo-controlled phase III intergroup study of gefitinib in patients with advanced NSCLC, non-progressing after first line platinum-based chemotherapy (EORTC 08021/ILCP 01/03)
Rabab M Gaafar, Veerle F Surmont, Giorgio V Scagliotti, et al.
Frontiers in Oncology
|
June 21, 2018
Invasive Aspergillosis Mimicking Metastatic Lung Cancer
Michiel J E G W Vanfleteren, Anne-Marie C Dingemans, Veerle F Surmont, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Expert Review of Anticancer Therapy
|
October 18, 2011
Raltitrexed in mesothelioma
Veerle F Surmont, Jan P van Meerbeeck
Critical Reviews in Oncology/Hematology
|
May 15, 2010
Malignant pleural mesothelioma: the standard of care and challenges for future management
Jan P van Meerbeeck, Arnaud Scherpereel, Veerle F Surmont, et al.
Expert Review of Anticancer Therapy
|
April 21, 2011
Malignant pleural mesothelioma: when is radiation therapy indicated?
Eric R E van Thiel, Veerle F Surmont, Jan P van Meerbeeck
Frontiers in Oncology
|
June 6, 2012
Investigational approaches for mesothelioma
Veerle F Surmont, Eric R E van Thiel, Karim Vermaelen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 31, 2015
Sunitinib (SU11248) in patients with chemo naive extensive small cell lung cancer or who have a 'chemosensitive' relapse: A single-arm phase II study (EORTC-08061)
Fatma Abdelraouf, Egbert Smit, Baktiar Hasan, et al.
Lung Cancer (Amsterdam, Netherlands)
|
April 17, 2002
Unexpected response of a pulmonary blastoma on radiotherapy: a case report and review of the literature
Veerle F Surmont, Rob J van Klaveren, Peter J C M Nowak, et al.
Cancers
|
July 9, 2022
External Validation of a Breath-Based Prediction Model for Malignant Pleural Mesothelioma
Eline Janssens, Eline Schillebeeckx, Kathleen Zwijsen, et al.
Journal of Breath Research
|
September 8, 2023
Determining the clinical utility of a breath test for screening an asbestos-exposed population for pleural mesothelioma: baseline results
Kathleen Zwijsen, Eline Schillebeeckx, Eline Janssens, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 2, 2011
A double-blind, randomised, placebo-controlled phase III intergroup study of gefitinib in patients with advanced NSCLC, non-progressing after first line platinum-based chemotherapy (EORTC 08021/ILCP 01/03)
Rabab M Gaafar, Veerle F Surmont, Giorgio V Scagliotti, et al.
Frontiers in Oncology
|
June 21, 2018
Invasive Aspergillosis Mimicking Metastatic Lung Cancer
Michiel J E G W Vanfleteren, Anne-Marie C Dingemans, Veerle F Surmont, et al.
Page
of 2